Stuart Essig

Managing Partner at Prettybrook Partners

Stuart Essig is a highly accomplished executive and board member in the life sciences industry. He was appointed as Chair of the Board of Directors at Mission Bio, a company pioneering high-throughput single-cell DNA and multi-omics analysis, in March 2022.1 2

Key points about Stuart Essig:

Professional Experience

Currently serves as Managing Director of Prettybrook Partners LLC, his family office investing in medical technology companies.4 5
Executive Chairman of Integra LifeSciences Holdings Corporation, where he previously served as CEO from 1997 to 2012, growing the company's revenues from $15 million to over $1 billion.1 2 3

Board Memberships

Chair of Mission Bio's Board of Directors (since March 2022)
Director for several public and private companies in the life sciences industry, including:
- Integra Lifesciences (NASDAQ: IART)
- IDEXX Laboratories (NASDAQ: IDXX)
- Orthofix Medical Inc. (since January 2023)

Financial Expertise

Senior Advisor to TowerBrook Capital Partners
Venture Partner at Wellington Partners
Former Managing Director at Goldman Sachs, specializing in medical device, pharmaceutical, and biotechnology sectors.1 2 3

Education

PhD in Financial Economics from the University of Chicago
MBA from the University of Chicago
BA from the School of Public and International Affairs at Princeton University3

Dr. Essig's extensive experience in leading high-growth companies, his financial acumen, and his deep understanding of the life sciences industry make him a valuable addition to Mission Bio's leadership team as they continue to expand their Tapestri Platform.1 2